We just received data on a new analyst forecast for $RDNT. Andrew Mok from Barclays set a price target of 86.0 for RDNT.
To track analyst ratings and price targets for $RDNT, check out Quiver Quantitative's $RDNT forecast page.
Should you buy $RDNT?
Some analysts are better than others. To view the past performance of Barclays, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$RDNT Price Targets
Multiple analysts have issued price targets for $RDNT recently. We have seen 4 analysts offer price targets for $RDNT in the last 6 months, with a median target of $80.5.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $86.0 on 11/13/2025
- David Macdonald from Truist Securities set a target price of $90.0 on 11/12/2025
- John Ransom from Raymond James set a target price of $75.0 on 08/13/2025
- Yuan Zhi from B. Riley Securities set a target price of $69.0 on 06/13/2025
$RDNT Insider Trading Activity
$RDNT insiders have traded $RDNT stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $RDNT stock by insiders over the last 6 months:
- RANJAN JAYANATHAN (Chief Information Officer) sold 65,598 shares for an estimated $4,427,865
- MARK STOLPER (EVP, Chief Financial Officer) sold 35,000 shares for an estimated $2,586,150
- DAVID JEFFREY KATZ (EVP and Chief Legal Officer) has made 0 purchases and 2 sales selling 31,000 shares for an estimated $2,203,430.
- NORMAN R HAMES (Pres and COO-West Operations) has made 0 purchases and 4 sales selling 23,447 shares for an estimated $1,589,720.
- STEPHEN M FORTHUBER (Pres & COO-Eastern Operations) sold 18,820 shares for an estimated $1,135,598
- MICHAEL N MURDOCK (EVP, Mergers and Acquisitions) sold 11,132 shares for an estimated $646,212
- LAWRENCE L LEVITT sold 5,000 shares for an estimated $305,450
- CORNELIS WESDORP (Pres & CEO, Digital Health) has made 0 purchases and 3 sales selling 2,500 shares for an estimated $172,530.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RDNT Hedge Fund Activity
We have seen 185 institutional investors add shares of $RDNT stock to their portfolio, and 139 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 890,124 shares (-89.4%) from their portfolio in Q2 2025, for an estimated $50,656,956
- VAN BERKOM & ASSOCIATES INC. added 817,808 shares (+14163.6%) to their portfolio in Q3 2025, for an estimated $62,325,147
- FULLER & THALER ASSET MANAGEMENT, INC. added 705,659 shares (+inf%) to their portfolio in Q3 2025, for an estimated $53,778,272
- AMERIPRISE FINANCIAL INC added 618,392 shares (+79.7%) to their portfolio in Q2 2025, for an estimated $35,192,688
- WESTFIELD CAPITAL MANAGEMENT CO LP added 525,820 shares (+inf%) to their portfolio in Q3 2025, for an estimated $40,072,742
- MILLENNIUM MANAGEMENT LLC removed 483,869 shares (-59.5%) from their portfolio in Q2 2025, for an estimated $27,536,984
- RTW INVESTMENTS, LP added 372,762 shares (+16.1%) to their portfolio in Q2 2025, for an estimated $21,213,885
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
